Australia: syphilis and chlamydia diagnoses fell after doxyPEP guidance for gay and bisexual men
A national Australian study tracked STI diagnoses in 78,560 gay and bisexual men from 2022 to 2025.
A national Australian study tracked STI diagnoses in 78,560 gay and bisexual men from 2022 to 2025.
On 20 October 2026 the FDA approved GSK's Hibsago (bepirovirsen) injection for chronic hepatitis B.
On 20 October 2026 WHO published State of inequality: noncommunicable diseases and their risk factors.
On 19 October 2026 WHO published the Global Breast Cancer Initiative (GBCI) Training Manual.
Saudi Arabia reported eight laboratory-confirmed MERS-CoV cases, including one death, between 1 January and 5 October 2026.
On 15 October 2026 the EMA recommended authorising Rasonque (daraxonrasib) for metastatic pancreatic adenocarcinoma.
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
A University of Oulu registry study followed 652 women with breast cancer that had spread to the bones.
On 9 October 2026 WHO released a guide to help countries move from institutional to community-based mental health care.
The CDC reported on a botulinum toxin product not approved by the FDA that was used at a Colorado medical spa.
Nothing more to show